Type 2 Diabetes
Disparities reported in use of cardioprotective drugs in type 2 diabetes
Among adults with type 2 diabetes, white men and white women and those seeing an endocrinologist receive more prescriptions for SGLT2 inhibitors and GLP-1 receptor agonists than Black adults and those seen only in primary care, data show.
Top in endocrinology: Mortality risk after fractures; study on biosimilar insulin
Poor physical performance measures in older men predicted their mortality risk after a bone fracture. It was the top story in endocrinology last week.
Health care professionals, patients agree on pathway for improving type 2 diabetes care
New results have suggested an alignment of the perceived needs and wishes for improved type 2 diabetes care among people with diabetes and health care professionals, although important health care gaps persist.
HbA1c self-testing deemed feasible for Black adults with type 2 diabetes
HbA1c self-testing was deemed feasible in a cohort of Black adults with type 2 diabetes, though HbA1c values are slightly lower with self-testing compared with use of a DCA laboratory device, according to study data.
Top in endocrinology: GLP-1 receptor agonists and dementia risk; premeal whey protein
A presenter at the Heart in Diabetes conference reported that GLP-1 receptor agonists may mitigate the risk for cognitive decline in patients with type 2 diabetes.
Biosimilar noninferior to insulin glargine with lower cost in type 2 diabetes
Among adults with type 2 diabetes, biosimilar insulin was noninferior to insulin glargine for lowering HbA1c, had similar safety and cost less, although not significantly, according to data.
Technology-based self-monitoring may be effective for type 2 diabetes, CKD weight loss
Nonsteroidal MRAs ‘save lives’ in diabetes with cardiorenal disease
PHILADELPHIA — For adults with type 2 diabetes and chronic kidney disease, a novel nonsteroidal mineralocorticoid receptor antagonist can play a key role in reducing risk for serious cardiorenal outcomes, according to a speaker.
Hypoglycemia risk high among older, Black patients with CKD, type 2 diabetes
Risk for hypoglycemia is higher among older Black adults with chronic kidney disease and type 2 diabetes compared with white patients, according to data published in Kidney Medicine.
Top in endocrinology: Nonalcoholic fatty liver disease in patients with obesity, diabetes
In a recent study, adults with overweight or obesity and nonalcoholic fatty liver disease who received daily subcutaneous growth hormone had a significant reduction in liver fat and inflammation compared with those who received placebo.